ASTH (ASTH) Tops Q1 EPS by 45c ; Offers Guidance

ASTH (NASDAQ: ASTH) reported Q1 EPS of $0.74, $0.45 better than the analyst estimate of $0.29. Revenue for the quarter came in at $965.1 million versus the consensus estimate of $951.55 million.

GUIDANCE:

ASTH sees Q2 2026 revenue of $0.96-1 billion, versus the consensus of $0.97 billion.

ASTH sees FY2026 revenue of $3.8-4.1 billion, versus the consensus of $3.98 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.

You May Also Be Interested In

• Waller: Recent Increases In Core Inflation Are Quite Broad
• MoonLake Immunotherapeutics (MLTX) call put ratio 4.9 calls to 1 put with a focus on July and August 25 calls
• U.S. Navy-led JMIC: U.S. military will begin enforcement of a naval blockade of all Iranian ports and Iranian coastal areas at 2000 GMT on 14 July